WHITE PAPER

SubQperior™ The Next Generation In Vivo Models

Standard implantation via subcutaneous injection can cause tumor ulceration resulting in early abrogation of your study, leaving you with too short treatment windows and high tumor heterogeneity and resulting in poor statistical value of your results.

Our Solution

To overcome these challenges, we have developed SubQperior™, a superior implantation method for syngeneic and human cell line-derived tumor models. In our SubQperior models tumor cells are implanted via mammary fat pad injection, resulting in

Larger tumors
Longer treatment windows
Homogenous and reliable tumor growth
Outstanding statistical value

Learn more about SubQperior by dowloading this White Paper

Terms and Conditions
Privacy Policy
Site Map
Contact Us
Company
FAQ